KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2025)

Historic Non-Current Deferred Tax Liability for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $478.0 million.

  • Elanco Animal Health's Non-Current Deferred Tax Liability fell 1131.73% to $478.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $478.0 million, marking a year-over-year decrease of 1131.73%. This contributed to the annual value of $449.0 million for FY2024, which is 5351.97% down from last year.
  • Per Elanco Animal Health's latest filing, its Non-Current Deferred Tax Liability stood at $478.0 million for Q3 2025, which was down 1131.73% from $496.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Non-Current Deferred Tax Liability registered a high of $1.1 billion during Q4 2021, and its lowest value of $449.0 million during Q4 2024.
  • Its 5-year average for Non-Current Deferred Tax Liability is $680.1 million, with a median of $643.0 million in 2023.
  • Per our database at Business Quant, Elanco Animal Health's Non-Current Deferred Tax Liability soared by 107099.24% in 2021 and then crashed by 5351.97% in 2024.
  • Elanco Animal Health's Non-Current Deferred Tax Liability (Quarter) stood at $1.1 billion in 2021, then decreased by 4.03% to $1.1 billion in 2022, then decreased by 9.89% to $966.0 million in 2023, then plummeted by 53.52% to $449.0 million in 2024, then increased by 6.46% to $478.0 million in 2025.
  • Its last three reported values are $478.0 million in Q3 2025, $496.0 million for Q2 2025, and $481.0 million during Q1 2025.